CVD Equipment grants Waldman two 11,100-share awards

Q: What is the vesting schedule for Lawrence Waldman’s CVV director grant?

The automatic 11,100-share grant was 25% vested upon grant. The remaining shares vest in equal 25% installments on December 31, 2026, March 31, 2027, and June 30, 2027, subject to continued service as a director on each applicable vesting date.

The automatic director grant vests in stages through June 2027, with later installments conditioned on continued board service.

Available on EDGAR 11/06/2026 - 02:27 PM EST Accepted by SEC EDGAR 11/06/2026 - 02:27 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

CVD Equipment Corp. (CVV) director Lawrence Waldman received two separate grants of 11,100 common shares each on November 5, 2026. The automatic director grant was issued under the Director Compensation Plan and 2022 Share Incentive Plan; 25% vested upon grant, with the remaining shares vesting in three equal 25% installments through June 30, 2027, subject to continued service as a director. The Board separately approved the other grant as additional compensation for contributions related to the company’s 2026 restructuring activities.

Insider Trade Summary

Grant/Award: 22,200 shares

Grant/Award 2 txns

Insider Waldman Lawrence

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock ^F1	11,100	$0.00	$0.00
Grant/Award	Common Stock ^F2	11,100	$0.00	$0.00

Holdings After Transaction: Common Stock — 101,346 shares (Direct)

Footnotes (2)

F1. Automatic grant issued on November 5, 2026, the date of the Company's 2026 Annual Meeting of Shareholders, pursuant to the Company's previously disclosed Director Compensation Plan. Such grant consists of Common Stock issued pursuant to the Company's 2022 Share Incentive Plan. Twenty-five percent of the shares were fully vested upon grant, and the remaining shares will vest in equal 25% installments on December 31, 2026, March 31, 2027 and June 30, 2027, subject to the recipient's continued service as a Director on each applicable vesting date.
F2. Represents a grant of Common Stock approved by the Board of Directors as additional compensation for the reporting person's contributions in connection with the Company's 2026 restructuring activities. The shares were issued on November 5, 2026, the date of the Company's 2026 Annual Meeting of Shareholders.

Key Figures

Automatic director grant: 11,100 shares Additional compensation grant: 11,100 shares Vested upon grant: 25% +1 more

4 metrics

Automatic director grant 11,100 shares Granted November 5, 2026

Additional compensation grant 11,100 shares Issued November 5, 2026

Vested upon grant 25% Automatic director grant

Vesting installments Equal 25% installments December 31, 2026; March 31, 2027; and June 30, 2027, subject to continued director service

Key Terms

Director Compensation Plan, 2022 Share Incentive Plan, vested

3 terms

Director Compensation Plan financial

"pursuant to the Company's previously disclosed Director Compensation Plan"

vested financial

"Twenty-five percent of the shares were fully vested upon grant"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did CVV director Lawrence Waldman receive?

Lawrence Waldman, a director of CVD Equipment Corp. (CVV), received two reported grants of 11,100 common shares each on November 5, 2026. One was an automatic director grant; the other was additional compensation approved by the Board for contributions in connection with the company’s 2026 restructuring activities.

What is the vesting schedule for Lawrence Waldman’s CVV director grant?

The automatic 11,100-share grant was 25% vested upon grant. The remaining shares vest in equal 25% installments on December 31, 2026, March 31, 2027, and June 30, 2027, subject to continued service as a director on each applicable vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Waldman Lawrence

(Last)

(First)

(Middle)

C/O CVD EQUIPMENT CORPORATION

355 S. TECHNOLOGY DRIVE

(Street)

CENTRAL ISLIP

NEW YORK

11722

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CVD EQUIPMENT CORP [ CVV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/05/2026		A		11,100⁽¹⁾	A	$0	90,246	D
Common Stock	11/05/2026		A		11,100⁽²⁾	A	$0	101,346	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Automatic grant issued on November 5, 2026, the date of the Company's 2026 Annual Meeting of Shareholders, pursuant to the Company's previously disclosed Director Compensation Plan. Such grant consists of Common Stock issued pursuant to the Company's 2022 Share Incentive Plan. Twenty-five percent of the shares were fully vested upon grant, and the remaining shares will vest in equal 25% installments on December 31, 2026, March 31, 2027 and June 30, 2027, subject to the recipient's continued service as a Director on each applicable vesting date.

2. Represents a grant of Common Stock approved by the Board of Directors as additional compensation for the reporting person's contributions in connection with the Company's 2026 restructuring activities. The shares were issued on November 5, 2026, the date of the Company's 2026 Annual Meeting of Shareholders.

	Lawrence Waldman	11/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR